Skandinaviska Enskilda Banken (SEB)’s LeMaitre Vascular LMAT Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-16,000	Closed	-$908K	–	879
2023 Q4	$908K	Hold	16,000	–	–	0.01%	708
2023 Q3	$872K	Sell	16,000 -3,300	-17%	-$196K	0.01%	695
2023 Q2	$1.3M	Sell	19,300 -400	-2%	-$24.4K	0.01%	655
2023 Q1	$1.01M	Buy	+19,700	New	+$956K	0.01%	687
2022 Q1	–	Sell	-17,400	Closed	-$886K	–	1033
2021 Q4	$886K	Hold	17,400	–	–	﹤0.01%	786
2021 Q3	$924K	Buy	+17,400	New	+$980K	0.01%	799

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s LMAT Position: Q1 2024 in Review

Skandinaviska Enskilda Banken (SEB) sold out of LeMaitre Vascular (LMAT) in Q1 2024, closing a stake of 16,000 shares — an estimated $908K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in LMAT in Q3 2021 and held it in 6 quarters. The position peaked at $1.3M in Q2 2023. 243 funds tracked by Wall St. Rank hold LMAT as of Q1 2024.

Skandinaviska Enskilda Banken (SEB) reported no remaining LeMaitre Vascular position as of Q1 2024 after selling out during the quarter.
Skandinaviska Enskilda Banken (SEB) sold 16,000 LeMaitre Vascular shares in Q1 2024, an estimated $908K.
Skandinaviska Enskilda Banken (SEB) first reported a position in LeMaitre Vascular in Q3 2021 and held it in 6 quarters.
Skandinaviska Enskilda Banken (SEB)'s LeMaitre Vascular position peaked at $1.3M in Q2 2023.
243 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2024.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q1 2024, filed 13 May 2024.